创新药、稀土永磁等题材反复活跃，沪指创年内收盘新高。 截至18日收盘，上证指数收涨0.5%，深证成指涨0.37%，创业板指涨0.34%。A股市场成交1.59万亿元，较昨日有所增加。 稀土永磁概念股再度走强 7月18日，稀土永磁概念股再度走强，中色股份、久吾高科、华宏科技等多股涨停，北方稀土、包钢股份等大涨。 消息面上，我国发现新稀土矿物。据中国地质大学官网消息，日前，国际矿物学协会-新矿物命名及分类委员会（IMA-CNMNC）全票批准通过了由中国地质大学杨 水源副研究员、赵来时研究员与内蒙古自治区地质调查研究院联合科研团队发现并申报的新矿物"钕黄河矿"（Huanghoite-（Nd）），批准号为IMA No.2025- 014。 钕黄河矿发现于内蒙古白云鄂博矿床主矿矿段的矿体中部。白云鄂博矿是世界最大的稀土矿床，也是我国矿物资源的宝库，此前已发现210余种矿物，且新矿物占 比逐年攀升。钕黄河矿的获批，进一步彰显了该矿床的复杂性与资源多样性。钕黄河矿的发现与获批，以及白云鄂博矿床中富钕族稀土矿物的发现，是在矿床成因 模式建立之后，理论指导新矿物发现的成果。该研究成果不仅丰富了稀土矿物学理论体系，还为钕资源的独立 ...

一、行情回顾 沪指全天震荡走强，创年内收盘新高，创业板指冲高回落。稀土永磁板块集体大涨，中色股份、东方锆业等涨停。锂矿股震荡走高，金圆股份、盛新锂能等 封板。创新药概念继续活跃，昂利康涨停，博瑞医药涨超10%，均创历史新高。下跌方面，光伏板块调整，亚玛顿跌停。个股涨跌互现，今日成交1.59万 亿。 二、当日热点 1.稀土磁材 稀土磁材板块今日反弹大涨，东方锆业、中色股份等涨停，北方稀土一度涨停，华宏科技反包。 据央视新闻报道，从中国地质大学(武汉)获悉，该校联合内蒙古自治区地质调查研究院，在内蒙古白云鄂博矿床主矿矿段的矿体中部，发现一种新稀土矿 物，命名为"钕黄河矿"。 | 股票名称 | 最新价 ◆ | 涨跌幅 = | 涨停时间 ◆ | 换手率 = | 流通市值 ◆ | | | --- | --- | --- | --- | --- | --- | --- | | 东方错业 | 11.86 | +10.02% | 09:45:06 | 11.64% | 89.87亿 | 公司涉 | | 002167.SZ | | | | | | 独居石 | | | | | | | | 稀土元 | | 中色股份 | 6.08 ...

Core Viewpoint - The A-share market continues to rotate, with cyclical stocks taking the lead today, particularly in sectors such as rare earths, chemicals, coal, and steel [1][2]. Group 1: Market Performance - The rare earth permanent magnet sector showed the strongest performance, with multiple stocks hitting the daily limit, including leading companies Northern Rare Earth and Baotou Steel Rare Earth [2]. - Previously adjusted sectors like banks, liquor, insurance, and solid-state batteries experienced a rebound today [3]. - The Shanghai Composite Index closed up 0.5%, the Shenzhen Component Index rose 0.37%, and the ChiNext Index increased by 0.34% [5]. Group 2: Significant Events - The Shanghai Composite Index reached a new high, closing at 3534.48 points, marking the highest closing point since January 2022 [9]. - Wavelength New Materials (688585) hit its eighth consecutive "20CM" limit-up, with a cumulative increase of over 330%, matching a record set earlier this year [10][12]. Group 3: AI Sector Developments - The AI agent sector was active today, with stocks like Century Tianhong, Yanhua Intelligent, and Zhizhen Technology experiencing significant gains [15]. - OpenAI recently demonstrated its ChatGPT agent, showcasing its capabilities in performing multiple tasks simultaneously, which may influence the AI application market [18]. - The AI agent industry is expected to mature by 2025, with a complete commercial cycle anticipated, indicating a significant growth opportunity in various sectors [19].

Market Performance - The A-share market has been experiencing a continuous upward trend, with the Shanghai Composite Index reaching a new closing high for the year on July 18, increasing by 0.5% [1] - A total of 2,603 stocks rose, while 2,567 stocks fell, indicating a generally positive market sentiment [2] Stock Movement - The total trading volume reached 15,933.19 billion, with a total of 5,418 stocks listed [3] - The rare earth permanent magnet sector saw significant gains, with companies like China Nonferrous Metal Industry's Foreign Engineering and Construction Co., Ltd. and Dongfang Zirconium Industry hitting the daily limit [4] Notable Stocks - In the innovative drug sector, companies such as Anglikang and Borui Pharmaceutical saw their stocks hit the daily limit and rise over 10%, respectively, both reaching historical highs [6] - Lithium mining stocks also showed strong performance, with Jin Yuan Co. and Shengxin Lithium Energy hitting the daily limit [7] Declining Stocks - The photovoltaic sector faced adjustments, with Yamaton hitting the daily limit down by 9.99% [9] - Other notable declines included ST Lifang and Huangshi Group, which fell by 8.00% and 7.42%, respectively [10] Sector Highlights - The photolithography machine concept sector strengthened towards the end of the trading day, with Hai Li Co. hitting the daily limit and companies like Zhongrun Optical and Kai Mei Teqi showing significant gains [11]

Market Overview - The A-share market has been experiencing a continuous upward trend, with the Shanghai Composite Index reaching a new closing high for the year on July 18, rising by 0.5% [1] - A total of 2,603 stocks rose, while 2,567 stocks fell, indicating a generally positive market sentiment [2] Stock Performance - The total trading volume reached 15,933.19 billion, with a total of 5,418 stocks traded [3] - The rare earth permanent magnet sector saw significant gains, with companies like China Northern Rare Earth Group and Dongfang Zirconium hitting the daily limit [4] - The innovative drug concept sector remained active, with Anglikang hitting the daily limit and Borui Pharmaceutical rising over 10%, both reaching historical highs [6] Sector Highlights - Lithium mining stocks also showed strong performance, with companies like Jinyuan Co. and Shengxin Lithium Energy hitting the daily limit [7] - The photovoltaic sector faced adjustments, with Yamaton hitting the daily limit down [9] - The photolithography machine concept sector strengthened towards the end of the trading day, with Haili Co. hitting the daily limit and Zhongrun Optics showing significant gains [11] Federal Reserve Developments - Federal Reserve Chairman Jerome Powell defended a $2.5 billion renovation project against criticism from White House officials, emphasizing the responsible use of public resources [13] - The renovation project has faced scrutiny due to rising costs attributed to inflation, as noted by Federal Reserve Governor Christopher Waller [14]

Core Viewpoint - The stock market showed a collective rise on July 18, with the Shanghai Composite Index closing at 3534.48 points, up 0.5%, indicating a positive market sentiment despite mixed performances across sectors [1]. Market Performance - The total trading volume in the Shanghai and Shenzhen markets reached 1.57 trillion yuan, an increase of 31.7 billion yuan compared to the previous trading day [1]. - A total of 2600 stocks rose while over 2500 stocks fell, reflecting a divergence in stock performance [1]. Sector Analysis - The rare earth permanent magnet sector experienced significant gains, with notable stocks such as Jiuwu Gaoke hitting a 20% limit up, and Huaxin Environmental Protection rising over 15% [3][4]. - The lithium extraction sector also saw a rise of 3.30%, while the gaming sector faced declines, with stocks like Ice River Network dropping over 4% [4][6]. - The innovative pharmaceutical sector surged in the afternoon, with stocks like Borui Pharmaceutical increasing over 14% [5]. Capital Flow - Main capital flows showed a net inflow into sectors such as non-ferrous metals, basic chemicals, and computers, while there was a net outflow from electronics, biomedicine, and light manufacturing sectors [8]. - Specific stocks that attracted significant net inflows included Northern Rare Earth (20.63 billion yuan), China National Petroleum Capital (10.4 billion yuan), and Wanhua Chemical (6.89 billion yuan) [9]. - Conversely, stocks like Changshan Beiming, Shenghong Technology, and Hengbao shares faced substantial net outflows of 11.87 billion yuan, 11 billion yuan, and 8.08 billion yuan respectively [10]. Institutional Insights - Jianghai Securities noted that market hotspots are dispersed, potentially leading to a structural market trend, while the overall index uptrend remains intact despite significant individual stock performance variations [12]. - CITIC Securities expressed optimism regarding investment opportunities in the non-bank sector, citing macroeconomic stabilization and liquidity release as positive factors for market activity [12].

Group 1 - The human-robot and innovative drug sectors are gaining market attention this year, with a strong outlook for innovative drugs in the second half of the year, characterized by high certainty and significant potential [1] - Domestic innovative drug companies are expected to leverage excellent clinical data, ongoing product internationalization, and commercialization to achieve better performance [1] - The upgrade of Chinese innovative drugs is seen as a necessary evolution rather than an option, with companies that possess hard technology and can continuously create clinical value likely to succeed [1] Group 2 - There is strong confidence in the potential of Chinese companies within the global AI wave, focusing on five core investment areas: AI infrastructure, AI applications, domestic AI supply chain, intelligent robotics and autonomous driving, and edge AI [1] - AI is viewed not just as a branch of technology but as a structural force driving the next round of global economic growth, representing a high-certainty and high-growth potential sector [1] Group 3 - As the largest carbon emitter globally, China is under pressure to meet carbon reduction commitments, while also being the largest manufacturing country, making manufacturing upgrades crucial for high-quality development [1] - The integration of manufacturing with artificial intelligence and low-carbon initiatives is seen as a vital path for technological innovation and investment opportunities [1] - Key areas for technological upgrades in Chinese manufacturing include solid-state batteries, perovskite photovoltaics, flying cars, autonomous driving, green data centers, and robotics [1] Group 4 - Future focus will continue on four directions: opportunities in the consumer sector, industries likely to benefit from stable growth expectations, national security and domestic substitution in specialized sectors, and high-tech manufacturing related to new productivity [1]

公募基金二季报陆续出炉，明星基金最新调仓动向浮出水面。 继一季度大手笔买入寒武纪后，傅鹏博二季度盯上了新易盛，二季度末持有730.86万股，持仓市值达9.28亿元，新进其第六大重仓股。 光模块龙头新易盛自2023年以来股价涨幅1502.9%，涨幅位居全市场第二。 新易盛发布2025年半年度业绩预告，预计实现盈利37-42亿元，同比增长327.7%-385.5%，单Q2实现盈利21.27-26.27亿元，中值为23.77亿元，同比增长 339.4%，环比Q1增长51.1%；公司业绩暴增主要受益于人工智能算力相关投资持续增长，产品结构优化，高速率产品需求持续增加。 1 傅鹏博、赵枫最新持仓动向来了 傅鹏博旗下基金最新前十大重仓股依次为：胜宏科技、腾讯控股、宁德时代、中国移动、立讯精密、新易盛、寒武纪、巨星科技、三诺生物、迈为股份。 较一季度末，二季度傅鹏博新进CPO龙头新易盛，油气开采股广汇能源则退出十大重仓股；二季度减持胜宏科技、腾讯控股、宁德时代、中国移动、三诺 生物、迈为股份；增持立讯精密、寒武纪、巨星科技。 | 证券代码 | 证券简称 | 持仓市值(亿元) | 持股数量(万股) | 占股票市值比(%) | ...

Group 1 - The Hong Kong Innovative Drug ETF (159567) closed with a gain of 0.56% on July 18, with a trading volume of 2.25 billion yuan [1] - The fund was established on January 3, 2024, with a management fee of 0.50% and a custody fee of 0.10% [1] - As of July 17, 2024, the fund's latest share count was 2.025 billion, with a total size of 3.63 billion yuan, reflecting an increase of 412.28% in shares and 860.92% in size since December 31, 2023 [1] Group 2 - The current fund manager is Ma Jun, who has managed the fund since its inception, achieving a return of 79.25% during the management period [2] - The top holdings of the fund include Innovent Biologics, WuXi Biologics, BeiGene, and others, with significant weightings such as 9.52% for Innovent Biologics and 9.47% for WuXi Biologics [2] - The fund's trading liquidity is strong, with a cumulative trading amount of 40.368 billion yuan over the last 20 trading days, averaging 2.018 billion yuan per day [1][2]

（原标题："沸腾"！又有两只，暴涨100%！） 【导读】又有两只基金业绩翻倍，年内"翻倍基"增至4只 中国基金报记者 张燕北 "翻倍基"又增加两只！ 创新药板块爆发，相关基金业绩上涨。截至7月17日，中银港股通医药A、永赢医药创新智选A年内单位 净值涨幅超100%，分别为年内第三只和第四只"翻倍基"。 受访基金经理表示，中期看好创新药板块的景气度。对于绝大部分中国创新药企业而言，能否进入新药 市场空间最大的欧美医药工业体系或是决定未来胜负的关键。 今年以来，重仓创新药的基金业绩领跑全市场。 除了上述四只"翻倍基"之外，截至7月17日，共计20只基金（仅统计主代码）年内单位净值涨幅超过 80%，绝大多数为聚焦创新药行业的主动或被动产品。 年内再添两只"翻倍基" 7月17日，创新药概念股强势爆发。当日，A股创新药板块指数涨幅超过3%，近20只相关概念股涨停或 涨幅超过10%；港股创新药多股创新高。 受此带动，一批医药主题基金当日净值大涨，助推年内业绩走高。截至7月17日收盘，中银港股通医药 A年内单位净值增长率达103.61%，永赢医药创新智选A涨幅达102.12%，成功跻身"翻倍基"阵营。 此前，汇添富香港优势 ...